Chemoinformaics analysis of ISOAROMADENDRENE EPOXIDE
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 15 |
| Exact Molecular Weight | 220.183 | nRing | 4 |
| Solubility: LogS | -4.921 | nHRing | 1 |
| Solubility: LogP | 4.088 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.569 |
| Synth | 4.564 |
| Natural Product Likeliness | 3.493 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.045 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.704 |
| MDCK | 0.000063 |
| BBB | 0.753 |
| PPB | 0.932969 |
| VDSS | 1.639 |
| FU | 0.0332961 |
| CYP1A2-inh | 0.188 |
| CYP1A2-sub | 0.518 |
| CYP2c19-inh | 0.089 |
| CYP2c19-sub | 0.933 |
| CYP2c9-inh | 0.229 |
| CYP2c9-sub | 0.165 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.623 |
| CYP3a4-inh | 0.094 |
| CYP3a4-sub | 0.444 |
| CL | 21.007 |
| T12 | 0.06 |
| hERG | 0.062 |
| Ames | 0.008 |
| ROA | 0.495 |
| SkinSen | 0.081 |
| Carcinogencity | 0.034 |
| EI | 0.018 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.820809 |